Norlin, Jenny M. http://orcid.org/0000-0001-5402-1884
Kellerborg, Klas http://orcid.org/0000-0002-7206-2847
Odin, Per http://orcid.org/0000-0002-0756-7478
Funding for this research was provided by:
AbbVie
Medtronic
Nordic infucare
Article History
Accepted: 5 June 2021
First Online: 7 July 2021
Declarations
:
: The research has received financial support from AbbVie, Medtronic and Nordic Infucare (Air Liquide Healthcare). The sponsors had no access to data. The authors had full independence regarding data collection, manuscript preparation, decision to publish, study design, interpretation, and analysis.
: PO has received honoraria for lectures and expert advice from AbbVie, Bial, Britannia, Global Kinetics, Lobsor, Nordic Infucare, PD Neurotechnology and Zambon. KK and JMN are employees at the Swedish Institute for Health Economics (IHE), which provides consulting services for a broad range of health care stakeholders, including national authorities, healthcare providers, branch organizations, and manufacturers.
: The study was performed in accordance with the Declaration of Helsinki and with approval from the Lund ethical review board. All patients have provided their informed consent to participate in PARKreg.
: Informed consent was obtained from all patients when enrolled in the PARKreg register. Patients can opt out from the register at any time.
: Not applicable.
: The data that support the findings of this study were retrieved from PARKreg. Restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available.
: Code from R is available from the authors upon request.
: JMN, KK and PO contributed to the conceptional framework and the study design. KK carried out the statistical analyses with contribution from JMN. JMN and KK wrote the manuscript with input from PO.
: We would like to thank patients, health care professionals, Swedish Movement Disorder Society and SWEPAR-net for using and advancing PARKreg.